+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Blood Transfusion Device Market - Growth, Trends, and Forecasts (2017 - 2022)

  • ID: 4402766
  • Report
  • Region: Global
  • 125 pages
  • Mordor Intelligence
1 of 5


  • Abbott
  • B.Braun
  • Becton Dickinson
  • Fenwal
  • Fresenius Kabi
  • Haemonetics
  • MORE
The global blood transfusion device market was valued at USD XX million in 2016. Considering the historical trend and possible future developments, the market is projected to reach USD XX million by 2022, with a CAGR of XX% over 2017-2022 (the forecast period).

Blood transfusion is a process of infusing the whole blood or blood components into systemic circulation intravenously. The report focuses on the market for medical devices and consumables employed for blood collection, processing, safety analyses, and storage during the transfusion process.


The market is mainly driven by increase in complex surgical procedures like heart and orthopedic surgeries. Increasing transfusion safety and rise in R&D initiatives in the field of regenerative medicine are contributing to the market expansion.


Stringent rules and regulations like approvals needed for separation of blood components limit the total number of end-users, thereby, reducing the market size.

Market Segmentation

The global blood transfusion device market has been segmented based on product type (blood collection, blood processing, blood safety, consumable & supplies, and others), by the end-user (hospital, blood bank, laboratory, plasma fractionation facility, and others) and by region (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)

The report provides a detailed overview of each type of blood transfusion device, along with an in-depth analysis, in addition to company profiles of major players in the space and a clear picture of a competitive landscape that currently exists in the market.

Some of the key players in the global blood transfusion device market include:

Macopharma, Becton Dickinson, B.Braun, Terumo, Haemonetics, Fresenius Kabi, Immucor, Fenwal, Abbott, etc.

Key Deliverables

Market analysis for the global blood transfusion device market, with region-specific assessments and competition analysis.

Market definition, along with the identification of key drivers, restraints, opportunities, and challenges.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section and company profiles of key players, with analysis of the current strategic interests and key financial information.

Identification and analysis of the macro and micro factors that affect the global blood transfusion device market.

Insights of the market in the regions that have the highest potential for growth and identification of untapped markets.

Related Topics:

Global Stem Cell Market Growth, Trends and Forecasts (2016-2021)
Regenerative Medicines Market - Growth, Trends, and Forecasts (2016-2021)
Global Injectable Drug Delivery Technology Market - Growth, Trends, and Forecasts (2016 - 2021)
Note: Product cover images may vary from those shown
2 of 5


  • Abbott
  • B.Braun
  • Becton Dickinson
  • Fenwal
  • Fresenius Kabi
  • Haemonetics
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Transfusion Safety
6.1.2 Rise in Complex Surgical Procedures
6.1.3 Increase in R&D Initiatives for Regenerative Medicine
6.2 Market Restraints
6.2.1 High Costs Associated with Handling of Blood and its Components
6.2.2 Strict Approval Process and Regulations
6.3 Opportunities
6.4 Key Challenges

7. Market Segmentation
7.1 Segmentation-By Product
7.1.1 Blood Collection Blood Bag and Accessory Blood Mixer Sealer Fridge and Freezer
7.1.2 Blood Processing Filter Inline Filter Dockable Filter Additive Solution Blood Component Separator Apheresis Device
7.1.3 Blood Safety Pathogen Reduction System For Plasma For Platelet For RBC Concentrate
7.1.4 Consumables and Supplies
7.1.5 Others
7.2 Segmentation-By End-user
7.2.1 Hospital
7.2.2 Blood Bank
7.2.3 Laboratory
7.2.4 Plasma Fractionation Facility
7.2.5 Others
7.3 Segmentation-By Geography
7.3.1 North America United States Canada Mexico
7.3.2 Europe France Germany United Kingdom Italy Spain Rest Of Europe
7.3.3 Asia-Pacific China Japan India Australia & New Zealand South Korea Rest Of Asia-Pacific
7.3.4 Middle East And Africa GCC South Africa Rest Of Middle East And Africa
7.3.5 South America Brazil Argentina Rest of South America

8. Competitive Landscape
8.1 Mergers and Acquisitions Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Product Launches

9. Key Players
9.1 Macopharma
9.2 Becton Dickinson
9.3 B.Braun
9.4 Terumo
9.5 Haemonetics
9.6 Fresenius Kabi
9.7 Immucor
9.8 Fenwal
9.9 Abbott
9.10 Others

10. Future of the Market
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Macopharma
  • Becton Dickinson
  • B.Braun
  • Terumo
  • Haemonetics
  • Fresenius Kabi
  • Immucor
  • Fenwal
  • Abbott
  • Others
Note: Product cover images may vary from those shown
5 of 5